Latest United States News

Shriro Holdings (ASX: SHM) posted a 7.5% revenue increase to $111 million for FY26, alongside a 44% jump in net profit after tax to $10.8 million. The company declared a fully franked final dividend and completed substantial share buy-backs, while guiding FY27 EBITDA to $12–15 million amid increased marketing spend.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

Recce Pharmaceuticals has secured ethics approval to add an active-controlled arm to its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, enabling head-to-head comparison against existing antibiotics.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

QEM Limited has finalized its acquisition of Idaho-based Big It and Columbite projects, gaining footholds in seven critical minerals including tungsten and niobium, aiming to mitigate US supply chain risks.

Ragusa Minerals has pinpointed 14 priority drill targets at its historic Black Rock Manganese Mine site in Arizona, following a detailed induced polarisation survey that reveals significant extensions of high-grade manganese mineralisation.

Pantera Minerals has kicked off its first-ever diamond drilling campaign at the Gillham Project in Arkansas, aiming to confirm high-grade antimony and silver mineralisation beneath historic mines.

Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.

Felix Gold's US subsidiary is in line for a substantial non-dilutive federal grant to advance its Treasure Creek antimony pilot processing facility, accelerating its plan for a domestic US supply chain.

Almonty Industries launches a US$300 million share repurchase program over three years, aiming to capitalise on undervalued shares ahead of full capacity at its Sangdong mine.

OD6 Metals consolidates progress across its rare earths, copper, and fluorspar assets with strong resource bases and ongoing development activities in Nevada, Western Australia, and New South Wales.

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.